Dhampur Bio Organics to review quarterly, half-yearly results

Dhampur Bio Organics Ltd. announced a board of directors meeting scheduled for Wednesday, November 12, 2025. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. This intimation was made pursuant to Regulations 29 and 50 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In conjunction with this, the trading window for the company's securities, which commenced its closure on September 26, 2025, will remain closed until November 14, 2025. This closure is in accordance with the company's "Code of Conduct" for the Prevention of Insider Trading.

All individuals subject to the code are advised against trading in the company's securities during this period. The company has requested that this information be taken on record.